Redhill Biopharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell RDHL and other ETFs, options, and stocks.About RDHL
RedHill Biopharma Ltd. engages in the development and commercialization of drugs for gastrointestinal (GI), infectious diseases, and oncology. The firm's products include Talicia, Movantik, and Aemcolo.
CEODror Ben-Asher
CEODror Ben-Asher
Employees35
Employees35
HeadquartersTel Aviv, Tel Aviv
HeadquartersTel Aviv, Tel Aviv
Founded2009
Founded2009
Employees35
Employees35
RDHL Key Statistics
Market cap3.56M
Market cap3.56M
Price-Earnings ratio-0.01
Price-Earnings ratio-0.01
Dividend yield—
Dividend yield—
Average volume2.97M
Average volume2.97M
High today$1.13
High today$1.13
Low today$1.06
Low today$1.06
Open price$1.09
Open price$1.09
Volume65.45K
Volume65.45K
52 Week high$8.75
52 Week high$8.75
52 Week low$1.02
52 Week low$1.02
Stock Snapshot
The current Redhill Biopharma(RDHL) stock price is $1.06, with a market capitalization of 3.56M. The stock trades at a price-to-earnings (P/E) ratio of -0.01.
On 2025-11-16, Redhill Biopharma(RDHL) stock moved within a range of $1.06 to $1.13. With shares now at $1.06, the stock is trading +0.1% above its intraday low and -5.9% below the session's peak.
Trading activity shows a volume of 65.45K, compared to an average daily volume of 2.97M.
Over the past 52 weeks, Redhill Biopharma(RDHL) stock has traded between a high of $8.75 and a low of $1.02.
Over the past 52 weeks, Redhill Biopharma(RDHL) stock has traded between a high of $8.75 and a low of $1.02.